NR1D1 and Hypercholesterolemia: Besides these two types of diseases, REV-ERBα has been implicated in the development of many other disorders such as hypercholesterolemia, obesity, dyslipidemia, and diabetes (Zhang et al., 2018b; Yuan et al., 2019; Zhang et al., 2019).